Felicitas Rataj - Concepedia

Author

Felicitas Rataj

Center for Integrated Protein Science Munich

Also Known As

F Rataj, F. Rataj, Felicitas Rataj, Rataj, Felicitas

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Center for Integrated Protein Science Munich Ludwig-Maximilians-Universität München German Center for Lung Research Helmholtz Zentrum München German Cancer Research Center

About

Felicitas Rataj is an author at Center for Integrated Protein Science Munich specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	353
2	Cell Biology	4	4	297
3	Biochemistry	2	2	28
4	Natural Sciences	1	1	18
5	Cellular Therapies	1	1	10

Felicitas Rataj

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR Dana Stenger, Tanja A. Stief, Theresa Kaeuferle, Blood	2020	176
T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours Stefanie Lesch, Viktoria Blumenberg, Stefan Stoiber, Nature Biomedical Engineering Cancer ImmunosurveillancePancreatic CancerT CellsMedicinePancreatic Tumours	2021	161
Cancer cells induce interleukin-22 production from memory CD4<sup>+</sup>T cells via interleukin-1 to promote tumor growth Cornelia Voigt, Peter May, Adrian Gottschlich, Proceedings of the National Academy of Sciences	2017	134
Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia Adrian Gottschlich, Moritz Thomas, Ruth Grünmeier, Nature Biotechnology Hematological MalignancyCar-t CellsMixed-phenotype Acute LeukemiaAcute Myeloid LeukemiaMalignant Blood Disorder	2023	102
Bifunctional PD-1 × αCD3 × αCD33 fusion protein reverses adaptive immune escape in acute myeloid leukemia Monika Herrmann, Christina Krupka, Katrin Deiser, Blood	2018	100
C-C chemokine receptor type-4 transduction of T cells enhances interaction with dendritic cells, tumor infiltration and therapeutic efficacy of adoptive T cell transfer Moritz Rapp, Simon Grassmann, Michael Chaloupka, OncoImmunology	2015	71
High-affinity CD16-polymorphism and Fc-engineered antibodies enable activity of CD16-chimeric antigen receptor-modified T cells for cancer therapy Felicitas Rataj, Severin Jacobi, Stefan Stoiber, British Journal of Cancer	2018	53
Bispecific Antibodies Enable Synthetic Agonistic Receptor-Transduced T Cells for Tumor Immunotherapy Clara H. Karches, Mohamed-Reda Benmebarek, Moritz L. Schmidbauer, Clinical Cancer Research	2019	43
Using Antigen-Specific B Cells to Combine Antibody and T Cell–Based Cancer Immunotherapy Kerstin Wennhold, Martin Thelen, Hans Schlößer, Cancer Immunology Research	2017	33
A modular and controllable T cell therapy platform for acute myeloid leukemia Mohamed-Reda Benmebarek, Bruno L. Cadilha, Monika Herrmann, Leukemia	2021	32

Page 1